In breast cancer, METTL3 directly targets BCL-2 by increasing the extent of the m6A modification of BCL-2 to increase its RNA and protein expression levels, thereby regulating the proliferation and apoptosis of breast cancer [70]. The gene discussed is BCL2; the disease is breast cancer.